Hyderabad: Hyderabad-based Monitra Healthcare raised an angel investment from Indian Angel Network, a seed stage platform in India. The funding round was led by IAN investors KNK Venkatraman and Dr Vinayendar Tulla the former joining the company board for further mentoring.
Monitra Healthcare focuses on reducing the dangers of cardiovascular diseases by facilitating real-time monitoring and pre-emptive cardiac care services to at-risk patients-anytime, anywhere in the world. The company has developed a biosensing platform, which consists of bio-sensing band aid-like skin patches, continuous 24×7 transmission to cloud, and real-time disease detection engine. All of this combines to provide early diagnosis of critical cardiovascular ailments and enables patients to seek treatment at an early stage for more effective medical intervention.
The startup was the brainchild of Ravi Bhogu. The company also boasts of a multi-disciplinary team which includes top medical professionals such as Aparna Bhogu, Sashank Bhogu and Archana Gollapudi, and has a combined experience in med-device commercialisation, information systems, databases and med-device project management.
On receiving fund from IAN, Ravi Bhogu, co-founder said, “Cardiovascular diseases command a general fear in the minds of people because of very few and very expensive treatment options available today. However, terrible as they sound, heart diseases and casualties suffered by cardiovascular patients and their families are avoidable if certain precautions are taken beforehand and the disease is diagnosed sooner. It is to make this a more accessible reality that we came up with our first product, upBeat, which comprises tech-enabled skin patches, continuous cloud connectivity, and real-time disease detection engine to facilitate early diagnosis for pre-emptive treatments.”
Targeting physicians who manage patients of heart rhythm disorder, Monitra’s flagship product upBeat will enable medical professionals worldwide to effectively diagnose a range of ailments including unexplained palpitations and fainting episodes. Physicians can also use the product to monitor both pre and post-surgery cardiac activity, and to assess the effectiveness of therapeutic drugs administered to control it.
Speaking on the announcement, IAN Lead investors – Dr Vinayendar Tulla & KNK Venkatraman commented, “Healthcare is the most basic necessity that every individual should have access to. One way this vision can become a reality, especially in a populous country like India, is by supporting emerging med-tech companies which are aiming to provide innovative healthcare solutions to everyday problems.”